Evidence map›Paper›PMID 37644174›Full record

SynthesisMolecular psychiatry2023

Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses.

Nerisa Banaj, Daniela Vecchio, Fabrizio Piras, Pietro De Rossi, Juan Bustillo, Simone Ciufolini, Paola Dazzan, Marta Di Forti, Erin W Dickie, Judith M Ford and 32 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Neuroanatomical Correlates of Negative Symptoms in Schizophrenia.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 9 countries.

Nerisa Banaj *Neuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy. n.banaj@hsantalucia.it.ORCID 0000-0002-6317-8549
Daniela Vecchio *Neuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.ORCID 0000-0001-8428-7376
Fabrizio PirasNeuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.ORCID 0000-0003-3566-5494
Pietro De RossiChild and Adolescence Neuropsychiatry Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Juan BustilloPsichiatry and Neuroscience, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0001-8730-8152
Simone CiufoliniPsychosis Studies, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
Paola DazzanDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
Marta Di FortiDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
Erin W DickieCenter for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON, Canada.ORCID 0000-0003-3028-9864
Judith M FordSan Francisco VA Health Care System, San Francisco, CA, USA.ORCID 0000-0002-6500-6548
Paola Fuentes-ClaramonteFIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
Oliver GruberSection for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.
Amalia Guerrero-PedrazaHospital Benito Menni CASM, Barcelona, Spain.
Holly K HamiltonSan Francisco VA Health Care System, San Francisco, CA, USA.
Fleur M HowellsDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa.
Bernd KraemerSection for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.ORCID 0000-0002-1145-9103
Stephen M LawrieDivision of Psychiatry, University of Edinburgh, Edinburg, EH10 5HF, UK.ORCID 0000-0002-2444-5675
Daniel H MathalonSan Francisco VA Health Care System, San Francisco, CA, USA.ORCID 0000-0001-6090-4974
Robin MurrayDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.ORCID 0000-0003-0829-0519
Edith Pomarol-ClotetFIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
Steven G PotkinDepartment of Psychiatry, University of California Irvine, Newfoundland, NJ, NJ 07435, USA.
Adrian PredaPsychiatry and Human Behavior, University of California Irvine, Orange, CA, 92868, USA.
Joaquim RaduaBiomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Anja RichterSection for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.
Raymond SalvadorFIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
Akira SawaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-1401-3008
Freda SchefflerDepartment of Psychiatry and Mental Health, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-8898-8599
Kang SimWest Region, Institute of Mental Health, National Healthcare Group, Singapore, Singapore.ORCID 0000-0003-3209-9626
Filip SpanielCARE, National Institute of Mental Health, Klecany, Czech Republic.ORCID 0000-0003-3479-696X
Dan J SteinSAMRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-7218-7810
Henk S TemminghDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa.
Sophia I ThomopoulosImaging Genetics Center, Mark & Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
David TomecekCARE, National Institute of Mental Health, Klecany, Czech Republic.ORCID 0000-0001-7038-0529
Anne UhlmannDepartment of child and adolescent psychiatry, TU Dresden, Dresden, Saxony, Germany.
Aristotle VoineskosCenter for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON, Canada.ORCID 0000-0003-0156-0395
Kun YangDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neda JahanshadImaging Genetics Center, Mark & Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.ORCID 0000-0003-4401-8950
Paul M ThompsonImaging Genetics Center, Mark & Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Theo G M Van ErpClinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.ORCID 0000-0002-2465-2797
Jessica A TurnerDepartment of Psychiatry and Behavioral Health, Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Gianfranco SpallettaNeuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
Federica PirasNeuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
Fondazione Santa Lucia · ITKing's College London · GBHeidelberg University · DEInstituto de Salud Carlos III · ESUniversity of California, Irvine · USUniversity of California, San Francisco · USUniversity of Cape Town · ZAUniversity of Southern California · USCentre for Addiction and Mental Health · CAJohns Hopkins University · USNational Institute of Mental Health · CZBambino Gesù Children's Hospital · ITBaylor College of Medicine · USFidmag Sisters Hospitallers · ESNational University of Singapore · SGSouth African Medical Research Council · ZATechnische Universität Dresden · DEThe Ohio State University Wexner Medical Center · USUniversity of Edinburgh · GBUniversity of New Mexico · US

Funding

FUNCTION BIRNU24RR021992 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI POTKIN, STEVEN G · 2006 to 2010
$25.0M
Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI AVRAMOPOULOS, DIMITRIOS · 2011 to 2020
$19.9M
BIO-INFORMATICS RESEARCH NETWORK COORDINATING CENTER (BIRN-CC)U24RR025736 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KESSELMAN, CARL · 2009 to 2011
$15.0M
ENIGMA-COINSTAC-APOE2 Functional and structural connectome protective mechanisms for Alzheimer’s disease and mood disorders: Request for supplemental funds for NIH R01:1R01MH121246R01MH121246 · NIMH · OHIO STATE UNIVERSITY · PI CALHOUN, VINCE D, TURNER, JESS · 2019 to 2023
$5.0M
High throughput marker for cognitive deficit: cellular autofluorescenceR01MH107730 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2018 to 2022
$3.0M
ENIGMA Bipolar Initiative: A Global Study of Imaging Genomics & Clinical OutcomesR01MH129742 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christopher Ching, PAUL M THOMPSON · 2022 to 2026
$3.0M
DISC1-dependent defects in neural fate, corticogenesis and cognition in psychosisR01MH105660 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ISHIZUKA, KOKO, SAWA, AKIRA · 2014 to 2018
$2.8M
ENIGMA-SD: Understanding Sex Differences in Global Mental Health through ENIGMAR01MH116147 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2021
$2.5M
Functional Brain Abnormalities in the Schizophrenia ProdromeR01MH076989 · NIMH · YALE UNIVERSITY · PI MATHALON, DANIEL H · 2007 to 2014
$2.3M
Oxidative stress and schizophrenia: combination of cell biology and brain imagingR01MH092443 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2015
$1.8M
Leveraging ethical dissension among capacity, beneficence and justice in clinical trials of neurotherapeutics in the severely disabled: lessons from schizophreniaRF1MH121362 · NIMH · UNIVERSITY OF COLORADO DENVER · PI DAVIS, RACHEL A, GAULT, JUDITH MORSE · 2019 to 2019
$1.6M
A global alliance to unlock brain mechanisms influencing suicidal behaviors through the ENIGMA ConsortiumR01MH117601 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JAHANSHAD, NEDA, SCHMAAL, LIANNE · 2018 to 2021
$1.5M
CIHRCSRD VA IK6 CX002519NCRR NIH HHS U24 RR021992NCRR NIH HHS U24 RR025736NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH076989NIMH NIH HHS R01 MH092443NIMH NIH HHS R01 MH105660NIMH NIH HHS R01 MH107730NIMH NIH HHS R01 MH116147NIMH NIH HHS R01 MH117601NIMH NIH HHS R01 MH121246NIMH NIH HHS R01 MH129742NIMH NIH HHS R21 MH097196NIMH NIH HHS RF1 MH121362
6 · The paper itself

Abstract

Converging evidence suggests that schizophrenia (SZ) with primary, enduring negative symptoms (i.e., Deficit SZ (DSZ)) represents a distinct entity within the SZ spectrum while the neurobiological underpinnings remain undetermined. In the largest dataset of DSZ and Non-Deficit (NDSZ), we conducted a meta-analysis of data from 1560 individuals (168 DSZ, 373 NDSZ, 1019 Healthy Controls (HC)) and a mega-analysis of a subsampled data from 944 individuals (115 DSZ, 254 NDSZ, 575 HC) collected across 9 worldwide research centers of the ENIGMA SZ Working Group (8 in the mega-analysis), to clarify whether they differ in terms of cortical morphology. In the meta-analysis, sites computed effect sizes for differences in cortical thickness and surface area between SZ and control groups using a harmonized pipeline. In the mega-analysis, cortical values of individuals with schizophrenia and control participants were analyzed across sites using mixed-model ANCOVAs. The meta-analysis of cortical thickness showed a converging pattern of widespread thinner cortex in fronto-parietal regions of the left hemisphere in both DSZ and NDSZ, when compared to HC. However, DSZ have more pronounced thickness abnormalities than NDSZ, mostly involving the right fronto-parietal cortices. As for surface area, NDSZ showed differences in fronto-parietal-temporo-occipital cortices as compared to HC, and in temporo-occipital cortices as compared to DSZ. Although DSZ and NDSZ show widespread overlapping regions of thinner cortex as compared to HC, cortical thinning seems to better typify DSZ, being more extensive and bilateral, while surface area alterations are more evident in NDSZ. Our findings demonstrate for the first time that DSZ and NDSZ are characterized by different neuroimaging phenotypes, supporting a nosological distinction between DSZ and NDSZ and point toward the separate disease hypothesis.

Indexed as

SchizophreniaCerebral CortexHumansMagnetic Resonance ImagingNeuroimagingParietal LobeSyndrome

Identifiers

PMID37644174
PMCPMC10827665
OpenAlexW4386254660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.